Ultrasound contrast agents can transform the role of ultrasound, allowing clinicians to study the enhancement patterns of liver lesions in real-time, providing faster and more definitive diagnoses. With Philips ultrasound, CEUS is seamlessly integrated into the standard workflow, providing exceptional detail throughout arterial, portal, and late phase scanning. Additionally, with advanced technologies such as MaxVue, the C5-1, mC12-3 and C9-2 PureWave transducers, fusion Imaging and integrated quantification via Philips Q-Apps, and the ultimate liver solution, maximum confidence becomes a reality even in the most challenging exams. Innovative solutions such as xMATRIX 3D/4D technology can also transform the assessment of lesions in the liver, providing a fast and effective way to visualize feeding vessels and response to treatment. There are many exciting developments in the field of CEUS. Learn more about Philips contrast-enhanced ultrasound imaging, and contact your local Philips representative by clicking the form below.